Godavari Biorefineries Limited — Updates, 07-07-2025: Press Release

Godavari Biorefineries has announced validation of its European patent for a novel anti-cancer molecule in Spain, the UK, and across multiple EU countries. The molecule, showing promise against breast and prostate cancers, is currently in Phase 1a clinical trials. This marks a key step in the company’s expansion beyond biofuels into clinical-stage biotech via its division Sathgen Therapeutics. With growing global patent protection and clinical progress, Godavari is intensifying focus on translational research while maintaining its leadership in renewable chemicals and biofuels.